OS Therapies Incorporated (OSTX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

OS Therapies Incorporated (OSTX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $84.2M, listed on AMEX, employing roughly 4 people, carrying a beta of -1.34 to the broader market. OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Led by Paul A. Romness, public since 2024-08-01.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for OSTX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →